100 related articles for article (PubMed ID: 27041399)
1. Design, synthesis, and evaluation of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives as Aurora kinase inhibitors.
Jeong Y; Lee J; Ryu JS
Bioorg Med Chem; 2016 May; 24(9):2114-24. PubMed ID: 27041399
[TBL] [Abstract][Full Text] [Related]
2. Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors.
Song D; Park Y; Yoon J; Aman W; Hah JM; Ryu JS
Bioorg Med Chem; 2014 Sep; 22(17):4855-66. PubMed ID: 25042560
[TBL] [Abstract][Full Text] [Related]
3. Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.
Long L; Wang YH; Zhuo JX; Tu ZC; Wu R; Yan M; Liu Q; Lu G
Eur J Med Chem; 2018 Sep; 157():1361-1375. PubMed ID: 30196060
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.
Zheng Y; Zheng M; Ling X; Liu Y; Xue Y; An L; Gu N; Ji M
Bioorg Med Chem Lett; 2013 Jun; 23(12):3523-30. PubMed ID: 23664099
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design.
Chang CF; Lin WH; Ke YY; Lin YS; Wang WC; Chen CH; Kuo PC; Hsu JTA; Uang BJ; Hsieh HP
Eur J Med Chem; 2016 Nov; 124():186-199. PubMed ID: 27573544
[TBL] [Abstract][Full Text] [Related]
6. CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors.
Chen YP; Lin HJ; Chen JS; Tsai MY; Hsieh HP; Chang JY; Chen NF; Chang KC; Huang WT; Su WC; Yang ST; Chang WC; Hung LY; Chen TY
Int J Cancer; 2014 Aug; 135(3):751-62. PubMed ID: 24382688
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.
Luo Y; Deng YQ; Wang J; Long ZJ; Tu ZC; Peng W; Zhang JQ; Liu Q; Lu G
Eur J Med Chem; 2014 May; 78():65-71. PubMed ID: 24681066
[TBL] [Abstract][Full Text] [Related]
8. Benzimidazole-Based Quinazolines: In Vitro Evaluation, Quantitative Structure-Activity Relationship, and Molecular Modeling as Aurora Kinase Inhibitors.
Sharma A; Luxami V; Saxena S; Paul K
Arch Pharm (Weinheim); 2016 Mar; 349(3):193-201. PubMed ID: 26773437
[TBL] [Abstract][Full Text] [Related]
9. Facile identification of dual FLT3-Aurora A inhibitors: a computer-guided drug design approach.
Chang Hsu Y; Ke YY; Shiao HY; Lee CC; Lin WH; Chen CH; Yen KJ; Hsu JT; Chang C; Hsieh HP
ChemMedChem; 2014 May; 9(5):953-61. PubMed ID: 24665000
[TBL] [Abstract][Full Text] [Related]
10. Systematic Computational Design and Identification of Low Picomolar Inhibitors of Aurora Kinase A.
Park H; Jung HY; Mah S; Hong S
J Chem Inf Model; 2018 Mar; 58(3):700-709. PubMed ID: 29401391
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity.
Cai J; Li L; Hong KH; Wu X; Chen J; Wang P; Cao M; Zong X; Ji M
Bioorg Med Chem; 2014 Nov; 22(21):5813-23. PubMed ID: 25270403
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 7-aryl-substituted (1,5-naphthyridin-4-yl)ureas as aurora kinase inhibitors.
Defaux J; Antoine M; Le Borgne M; Schuster T; Seipelt I; Aicher B; Teifel M; Günther E; Gerlach M; Marchand P
ChemMedChem; 2014 Jan; 9(1):217-32. PubMed ID: 24273104
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles as transforming growth factor-β type 1 receptor kinase inhibitors.
Li F; Park Y; Hah JM; Ryu JS
Bioorg Med Chem Lett; 2013 Feb; 23(4):1083-6. PubMed ID: 23294702
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.
Kilchmann F; Marcaida MJ; Kotak S; Schick T; Boss SD; Awale M; Gönczy P; Reymond JL
J Med Chem; 2016 Aug; 59(15):7188-211. PubMed ID: 27391133
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel inhibitors of Aurora A with a 3-(pyrrolopyridin-2-yl)indazole scaffold.
Song P; Chen M; Ma X; Xu L; Liu T; Zhou Y; Hu Y
Bioorg Med Chem; 2015 Apr; 23(8):1858-68. PubMed ID: 25771484
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B.
Gyulavári P; Szokol B; Szabadkai I; Brauswetter D; Bánhegyi P; Varga A; Markó P; Boros S; Illyés E; Szántai-Kis C; Krekó M; Czudor Z; Őrfi L
Bioorg Med Chem Lett; 2018 Oct; 28(19):3265-3270. PubMed ID: 30143423
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties.
Bellany F; Tsuchiya Y; Tran TM; Chan AWE; Allan H; Gout I; Tabor AB
Bioorg Med Chem; 2020 Nov; 28(22):115740. PubMed ID: 33007553
[TBL] [Abstract][Full Text] [Related]
18. Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
Jung Y; Shin SY; Yong Y; Jung H; Ahn S; Lee YH; Lim Y
Chem Biol Drug Des; 2015 May; 85(5):574-85. PubMed ID: 25298094
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening.
Kong Y; Bender A; Yan A
J Chem Inf Model; 2018 Jan; 58(1):36-47. PubMed ID: 29202231
[TBL] [Abstract][Full Text] [Related]
20. Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one derivatives as Aurora A kinase inhibitors: LQTA-QSAR analysis and detailed systematic validation of the developed model.
Kanhed AM; Dash RC; Parmar N; Das TK; Giridhar R; Yadav MR
Mol Divers; 2015 Nov; 19(4):965-74. PubMed ID: 26183841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]